Catalist debutant SPCH aims to be one-stop pain shop


THE domestic market is Singapore Paincare Holdings (SPCH)'s only nerve centre. But the company has Malaysia and Indonesia in its expansion crosshairs.

SPCH treats pain from the neck to the back and leg, as well as from cancer. It made its Catalist debut on Thursday,